| Dr Gary M Snyder, MD | |
|
3629 Bell Blvd Ste 202, Bayside, NY 11361-2056 | |
| (718) 423-4091 | |
| (718) 428-6667 |
| Full Name | Dr Gary M Snyder |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 45 Years |
| Location | 3629 Bell Blvd Ste 202, Bayside, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427016500 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent And Allergy Associates Llp | 0749193662 | 368 |
News Archive
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
Conmed Healthcare Management, Inc. today announced financial results for its fourth quarter and year ended December 31, 2010.
Subthalamic nucleus deep brain stimulation has a beneficial effect on pain severity in patients with Parkinson's disease that persists for up to 8 years, say researchers, but new onset of musculoskeletal pain in many suggests its effects are not enduring.
› Verified 1 days ago
| Entity Name | Ent And Allergy Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598326 PECOS PAC ID: 0749193662 Enrollment ID: O20031107000043 |
News Archive
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
Conmed Healthcare Management, Inc. today announced financial results for its fourth quarter and year ended December 31, 2010.
Subthalamic nucleus deep brain stimulation has a beneficial effect on pain severity in patients with Parkinson's disease that persists for up to 8 years, say researchers, but new onset of musculoskeletal pain in many suggests its effects are not enduring.
› Verified 1 days ago
| Entity Name | Ear, Nose & Throat Associates Of New York,p.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124079769 PECOS PAC ID: 0143111328 Enrollment ID: O20040324001573 |
News Archive
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
Conmed Healthcare Management, Inc. today announced financial results for its fourth quarter and year ended December 31, 2010.
Subthalamic nucleus deep brain stimulation has a beneficial effect on pain severity in patients with Parkinson's disease that persists for up to 8 years, say researchers, but new onset of musculoskeletal pain in many suggests its effects are not enduring.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gary M Snyder, MD 660 White Plains Rd Ste 400, Tarrytown, NY 10591-5107 Ph: (914) 984-2546 | Dr Gary M Snyder, MD 3629 Bell Blvd Ste 202, Bayside, NY 11361-2056 Ph: (718) 423-4091 |
News Archive
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
Conmed Healthcare Management, Inc. today announced financial results for its fourth quarter and year ended December 31, 2010.
Subthalamic nucleus deep brain stimulation has a beneficial effect on pain severity in patients with Parkinson's disease that persists for up to 8 years, say researchers, but new onset of musculoskeletal pain in many suggests its effects are not enduring.
› Verified 1 days ago